Gillian C. Ivers-Read

2018

In 2018, Gillian C. Ivers-Read earned a total compensation of $1.8M as EVP and Chief Regulatory Officer at Clovis Oncology, a 26% decrease compared to previous year.

Compensation breakdown

Bonus$180,098
Option Awards$474,240
Salary$448,060
Stock Awards$642,730
Other$18,892
Total$1,764,020

Ivers-Read received $642.7K in stock awards, accounting for 36% of the total pay in 2018.

Ivers-Read also received $180.1K in bonus, $474.2K in option awards, $448.1K in salary and $18.9K in other compensation.

Rankings

In 2018, Gillian C. Ivers-Read's compensation ranked 6,356th out of 14,244 executives tracked by ExecPay. In other words, Ivers-Read earned more than 55.4% of executives.

ClassificationRankingPercentile
All
6,356
out of 14,244
55th
Division
Manufacturing
2,430
out of 5,759
58th
Major group
Chemicals And Allied Products
904
out of 2,122
57th
Industry group
Drugs
759
out of 1,811
58th
Industry
Pharmaceutical Preparations
588
out of 1,385
58th

Pay ratio

Gillian C. Ivers-Read's Pay$1,764,020
Median Employee's Pay$349,809
Pay Ratio

5

to 1

In 2018, the annual total compensation of Gillian C. Ivers-Read was $1,764,020.

The annual total compensation of the median employee at Clovis Oncology was $349,809.

The ratio of Gillian C. Ivers-Read's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 26, 2019.

Ivers-Read's colleagues

We found four more compensation records of executives who worked with Gillian C. Ivers-Read at Clovis Oncology in 2018.

2018

Patrick Mahaffy

Clovis Oncology

Chief Executive Officer

2018

Lindsey Rolfe

Clovis Oncology

Chief Medical Officer

2018

C Hooks

Clovis Oncology

Former Senior VP and Chief Commercial Officer

2018

Daniel Muehl

Clovis Oncology

Senior VP of Finance, Principal Accounting Officer, and Principal Financial Officer

News

You may also like